Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
What's the best peptide combination for body recomposition
selective NNMT inhibitors such as 5-Amino-1MQ are prominent tool compounds for target validation [2,8,9]
Further research with these compounds will likely reveal more applications and deepen our understanding of cellular metabolism
US$ 20.32
![D-Asp15]-Tirzepatide](https://www.daicelpharmastandards.com/wp-content/uploads/2024/02/dcti-d-312.png)
US$ 24.15
US$ 27.97
